Agreena has secured a seven-year agreement with one of the world’s largest commodity trading houses for the purcha…

Expanding research is identifying nutrition as a missing piece in GLP-1-related skin changes, giving rise to a new segment of beauty products built around nutrients that support the skin during GLP-1 use.

Attention-deficit/hyperactivity disorder (ADHD), marked by excessive activity and impulsivity, is linked to changes in the brain’s dopamine system, though the mechanisms remain unclear. Researchers at the University of Fukui have now found that in genetically modified, conditional knockout mice, loss of a protein called N-ethylmaleimide-sensitive factor (NSF)—which is linked to dopamine receptors—in D2 receptor-expressing cells led to lower dopamine levels and ADHD-like behaviors. Their results also pointed to a potential therapeutic strategy.

Why it matters: Sensorion is already listed on Euronext Growth in Paris, where it made its IPO in 2015. A U.S. listing would give the hearing-loss specialist another route to investors as it focuses its gene therapy pipeline around SENS-601.

Colgate-Palmolive is exploring the sale of several mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, according to reports. The consumer goods group is said to be reviewing its portfolio amid intensifying competition in the US.

dsm-firmenich is broadening its fragrance and beauty capabilities in Indonesia with a new Jakarta center featuring creation and application labs, sensory facilities, and air care testing capabilities.

Medicos Group, a packaging solution provider based in France, has developed the packaging for Phyto Paris’ Phytocyane Intensive+ treatment, featuring a box containing 12 tubular glass single-dose vials. Each vial is fitted with a polypropylene (PP) cap and accompanied by a single “ergonomic, removable, reusable, and unisex PP applicator.” 

Researchers at Virginia Tech have developed a prophylactic phage therapy approach to protecting against potential future infections by pathogenic gut bacteria. Bacteriophages, or phages, are viruses of bacteria and do not infect humans or animals. Headed by associate professor and Blackwood Junior Faculty Fellow Bryan Hsu, PhD, the team engineered a nonpathogenic Escherichia coli bacterium that produces a phage targeting the enteric pathogen Salmonella enterica Typhimurium (STm).

The genome editing toolbox provides unprecedented opportunities to engineer the human genome. However, genome editing for therapeutic benefit continues to have its limitations. Most current methods rely on untargeted gene delivery or short DNA edits that need to be individualized to each patient.